928775-00-2

Upstream product

• 24424-99-5 di-tert-butyl dicarbonate 
• 928774-98-5 2,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepine hydrochloride 
• 928774-99-6 1,1-dimethylethyl 4-formyl-5-oxohexahydro-1H-azepine-1-carboxylate 
• 111416-15-0 2,4,5,6,7,8-hexahydro-pyrazolo[3,4-d]azepine 
• 928774-98-5 2,4,5,6,7,8-hexahydropyrazolo[3,4-d]azepine hydrochloride 

Downstream Products

• 928775-01-3 1,1-dimethylethyl 2-(4-cyanophenyl)-4,5,7,8-tetrahydropyrazolo[3,4-d]azepine-6(2H)-carboxylate 
• 1258976-29-2 1,1-dimethylethyl 1-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3,4-thiadiazol-2-yl)-4,5,7,8-tetrahydropyrazolo[3,4-d]azepine-6(2H)-carboxylate 
• 1258976-28-1 1,1-dimethylethyl 2-(5-{3-chloro-4-[(1-methylethyl)oxy]phenyl}-1,3,4-thiadiazol-2-yl)-4,5,7,8-tetrahydropyrazolo[3,4-d]azepine-6(2H)-carboxylate 

Relevant academic research and scientific papers

THIADIAZOLE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF DISORDERS MEDIATED BY SLPL RECEPTORS

The present invention relates to novel compounds having pharmacological activity, processes for their preparation, pharmaceutical compositions containing them and their use in the treatment of various disorders.

PYRAZOLO [3 , 4-D] AZEPINE DERIVATIVES AS HISTAMINE H3 ANTAGONISTS

The present invention relates to novel pyrazole derivatives of formula I having pharmacological activity as H3 antagonists processes for their preparation, to compositions containing them and to their use in the treatment of neurological and psychiatric disorders.